Amended Statement of Beneficial Ownership (3/a)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * Peters Joseph B	2. Date of Event Requiring Statement (MM/DD/YYYY) 4/20/2017	3. Issuer Name and Ticker or Trading Symbol HealthWarehouse.com, Inc. [HEWA]
(Last)        (First)        (Middle) 7107 INDUSTRIAL ROAD	4. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director                            _____ 10% Owner ___ X ___ Officer (give title below)          _____ Other (specify below) Interim President and CEO /
(Street) FLORENCE, KY 41042        (City)              (State)              (Zip)	5. If Amendment, Date Original Filed (MM/DD/YYYY) 4/11/2017	6. Individual or Joint/Group Filing (Check Applicable Line) _ X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Shares	0	D

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Shares	(1)	4/3/2025	Common Shares	100000	$.09	D
Common Shares	(2)	8/5/2025	Common Shares	100000	$.11	D
Common Shares	(2)	11/9/2026	Common Shares	1000	$.35	D
Common Shares	(2)	12/23/2023	Common Shares	40000	$.53	D
Common Shares	(2)	2/15/2023	Common Shares	7000	$1.60	D
Common Shares	(2)	10/15/2022	Common Shares	3000	$4.95	D
Common Shares	(2)	3/30/2022	Common Shares	15000	$6.99	D

Explanation of Responses:
(1)	The option vests one-third on 4/3/16, one-third on 4/3/17, and one-third on 12/4/17.
(2)	The options vest one-third on the first anniversary of the grant date, one-third on the second anniversary of the grant date, and one third on the third anniversary of the grant date.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Peters Joseph B 7107 INDUSTRIAL ROAD FLORENCE, KY 41042			Interim President and CEO

Signatures
/s/ F. Mark Reuter, as Attorney-in-Fact for Joseph Peters		4/20/2017
** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.